Cytosorbents (CTSO) Enterprise Value (2010 - 2026)
Cytosorbents' (CTSO) quarterly Enterprise Value came in at -$4.8 million in Q1 2026, up 63.39% YoY from -$2.9 million in Q1 2025, and up 23.19% on a QoQ basis from -$6.2 million in Q4 2025.
Cytosorbents (CTSO) Enterprise Value (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Enterprise Value data on file, last reported at -$4.8 million in Q1 2026.
- Quarterly Enterprise Value rose 63.39% year-over-year to -$4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.8 million (up 63.39% YoY) and the FY2025 annual result came in at -$6.2 million, up 57.67% from the prior year.
- Enterprise Value grew to -$4.8 million in Q1 2026, from -$6.2 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$4.8 million in Q1 2026 to a low of -$43.0 million in Q1 2022.
- A 5-year average of -$14.9 million and a median of -$13.1 million in 2025 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2025 — Enterprise Value plunged 52.29% — and 2026, when it soared 63.39%.
- Tracing CTSO's Enterprise Value over 5 years: stood at -$22.1 million in 2022, then jumped by 36.19% to -$14.1 million in 2023, then fell by 4.48% to -$14.8 million in 2024, then surged by 57.67% to -$6.2 million in 2025, then grew by 23.19% to -$4.8 million in 2026.
- The last three Enterprise Value figures came in at -$4.8 million (Q1 2026), -$6.2 million (Q4 2025), and -$7.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | -4.95 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | -3.48 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | -297.00 Mn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | -4.15 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | -1.95 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | -1.88 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -3.29 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | -467.80 Mn |
| 10 | Cytosorbents | 21.42 Mn | 17.01 Mn | 7.05 Mn | -4.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.41 Mn |
| Mar 31, 2026 | -4.80 Mn |
| Dec 31, 2025 | -6.25 Mn |
| Sep 30, 2025 | -7.54 Mn |
| Jun 30, 2025 | -10.20 Mn |
| Mar 31, 2025 | -13.11 Mn |
| Dec 31, 2024 | -14.76 Mn |
| Sep 30, 2024 | -6.50 Mn |
| Jun 30, 2024 | -8.46 Mn |
| Mar 31, 2024 | -8.61 Mn |
| Dec 31, 2023 | -14.13 Mn |
| Sep 30, 2023 | -8.36 Mn |
| Jun 30, 2023 | -13.15 Mn |
| Mar 31, 2023 | -19.05 Mn |
| Dec 31, 2022 | -22.14 Mn |
| Sep 30, 2022 | -22.55 Mn |
| Jun 30, 2022 | -30.16 Mn |
| Mar 31, 2022 | -43.02 Mn |
| Dec 31, 2021 | -52.14 Mn |
| Sep 30, 2021 | -61.04 Mn |